Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease

dc.contributor.authorYılmaz, Yusuf
dc.contributor.authorAkın, Hakan Levent
dc.contributor.authorÇolak, Yaşar
dc.contributor.authorÖztürk, Oğuzhan
dc.contributor.authorŞenateş, Ebubekir
dc.contributor.authorTuncer, İlyas
dc.contributor.buuauthorAyyıldız, Talat
dc.contributor.buuauthorDolar, Enver
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0001-8944-2793tr_TR
dc.contributor.researcheridAAG-9177-2021tr_TR
dc.contributor.scopusid6603155277tr_TR
dc.contributor.scopusid6602075084tr_TR
dc.date.accessioned2022-08-23T10:22:56Z
dc.date.available2022-08-23T10:22:56Z
dc.date.issued2014-05
dc.description.abstractBackground/Aims: We sought to examine whether the presence of gallstone disease (GD) in patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD) is associated with liver fibrosis and histological nonalcoholic steatohepatitis (NASH) score. Methods: We included 441 Turkish patients with biopsy-proven NAFLD. GD was diagnosed in the presence of sonographic evidence of gallstones, echogenic material within the gallbladder with constant shadowing and little or no visualization of the gallbladder or absence of gallbladder at ultrasonography, coupled with a history of cholecystectomy. Results: Fifty-four patients (12.2%) had GD (GD+ subjects). Compared with the GD- subjects, GD+ patients were older, had a higher body mass index and were more likely to be female and have metabolic syndrome. However, GD+ patients did not have a higher risk of advanced fibrosis or definite NASH on histology. After adjustment for potential confounding variables, the prevalence of GD in NAFLD patients was not associated with significant fibrosis (>= 2) (odds ratio [OR], 1.06; 95% confidence interval [Cl], 0.53 to 2.21; p=0.68) or definite NASH (OR, 1.03; 95% Cl, 0.495 to 2.12; p=0.84). Conclusions: The presence of GD is not independently associated with advanced fibrosis and definite NASH in adult Turkish patients with biopsy-proven NAFLD.en_US
dc.identifier.citationYılmaz, Y. vd. (2014). "Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease". Gut and Liver, 8(3), 313-317.en_US
dc.identifier.endpage317tr_TR
dc.identifier.issn1976-2283
dc.identifier.issn2005-1212
dc.identifier.issue3tr_TR
dc.identifier.pubmed24827629tr_TR
dc.identifier.scopus2-s2.0-84901237349tr_TR
dc.identifier.startpage313tr_TR
dc.identifier.urihttps://doi.org/10.5009/gnl.2014.8.3.313
dc.identifier.urihttps://www.gutnliver.org/journal/view.html?volume=8&number=3&spage=313&year=2014
dc.identifier.urihttp://hdl.handle.net/11452/28322
dc.identifier.volume8tr_TR
dc.identifier.wos000336008400013tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherEditorial Office Gut & Liveren_US
dc.relation.collaborationYurt içitr_TR
dc.relation.journalGut and Liveren_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGallstone diseaseen_US
dc.subjectNon-alcoholic fatty liver diseaseen_US
dc.subjectNonalcoholic steatohepatitisen_US
dc.subjectFibrosisen_US
dc.subjectMetabolic syndromeen_US
dc.subjectGallbladder-diseaseen_US
dc.subjectInsulin-resistanceen_US
dc.subjectRisk-factorsen_US
dc.subjectSteatohepatitisen_US
dc.subjectProgressionen_US
dc.subjectPrevalenceen_US
dc.subjectGastroenterology & hepatologyen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBody massen_US
dc.subject.emtreeCholelithiasisen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeEchographyen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeGallbladderen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHuman tissueen_US
dc.subject.emtreeLiver fibrosisen_US
dc.subject.emtreeLiver histologyen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMetabolic syndrome Xen_US
dc.subject.emtreeNonalcoholic fatty liveren_US
dc.subject.emtreeBiopsyen_US
dc.subject.emtreeClinical trialen_US
dc.subject.emtreeComplicationen_US
dc.subject.emtreeEvaluation studyen_US
dc.subject.emtreeFatty liveren_US
dc.subject.emtreeGallstoneen_US
dc.subject.emtreeLiveren_US
dc.subject.emtreeLiver cirrhosisen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreeMulticenter studyen_US
dc.subject.emtreeNonalcoholic fatty liveren_US
dc.subject.emtreePathologyen_US
dc.subject.emtreeProspective studyen_US
dc.subject.emtreeRetrospective studyen_US
dc.subject.emtreeSensitivity and specificityen_US
dc.subject.meshBiopsyen_US
dc.subject.meshFatty liveren_US
dc.subject.meshFemaleen_US
dc.subject.meshGallbladderen_US
dc.subject.meshGallstonesen_US
dc.subject.meshHumansen_US
dc.subject.meshLiveren_US
dc.subject.meshLiver cirrhosisen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshNon-alcoholic fatty liver diseaseen_US
dc.subject.meshProspective studiesen_US
dc.subject.meshRetrospective studyen_US
dc.subject.meshSensitivity and specificityen_US
dc.subject.scopusGallstones; Nonalcoholic Fatty Liver; Cholelithiasisen_US
dc.subject.wosGastroenterology & hepatologyen_US
dc.titleGallstone disease does not predict liver histology in nonalcoholic fatty liver diseaseen_US
dc.typeArticle
dc.wos.quartileQ4en_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ayıldız_vd_2014.pdf
Size:
266.77 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: